CHRISTINA GREEN: Open Payments
NPI 1619321163 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 72 payments from 12 companies in 2025. Trend: 2023 $906 · 2024 $805 · 2025 $1,176
Food & beverage: $1,097Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $330 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $196 |
| Vanda Pharmaceuticals Inc. | 9 | $135 |
| Neurocrine BioSciences, Inc. | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 2 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Alkermes, Inc. | 4 | $77 |
| Axsome Therapeutics, Inc. | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, FANAPT, INGREZZA, REXULTI, Auvelity, LYBALVI, COBENFY.
Industry payments across TX — which companies pay providers there.
